Quantum Cyber N.V. Cash Flows From Used In Operating Activities
Quantum Cyber N.V. (QUCY) reported Cash Flows From Used In Operating Activities of -$6.52 million for the 6-month period ending 2025-06-30, per its 6-K filed 2025-09-26.
Financial Statements › Cash Flow › Operating Activities
ifrs-full:CashFlowsFromUsedInOperatingActivities · last filed 2025-09-26
- Quantum Cyber N.V. cash flows from used in operating activities for the quarter ending 2023-12-31 was -$4.66M.
- Quantum Cyber N.V. cash flows from used in operating activities for the quarter ending 2023-09-30 was -$6.51M.
- Quantum Cyber N.V. cash flows from used in operating activities for the quarter ending 2023-06-30 was -$5.12M.
- Quantum Cyber N.V. cash flows from used in operating activities for the quarter ending 2023-03-31 was -$5.66M.
| Period end | Cash Flows From Used In Operating Activities 3 month | Cash Flows From Used In Operating Activities 6 month | Cash Flows From Used In Operating Activities 9 month | Cash Flows From Used In Operating Activities 12 month |
|---|---|---|---|---|
| 2025-06-30 | -$6.52M 6-K · filed 2025-09-26 | |||
| 2024-12-31 | -$17.09M 20-F · filed 2025-03-31 | |||
| 2024-06-30 | -$8.14M 6-K · filed 2025-09-26 | |||
| 2023-12-31 | -$4.66M derived: 20-F 12 month − 6-K 9 month · filed 2025-03-31 | -$11.16M derived: sum of 2 quarters · filed 2025-03-31 | -$16.28M derived: sum of 3 quarters · filed 2025-03-31 | -$21.94M 20-F · filed 2025-03-31 |
| 2023-09-30 | -$6.51M derived: 6-K 9 month − 6-K 6 month · filed 2023-11-16 | -$11.62M derived: sum of 2 quarters · filed 2024-10-18 | -$17.28M 6-K · filed 2023-11-16 | -$22.00M derived: sum of 4 quarters · filed 2025-03-31 |
| 2023-06-30 | -$5.12M derived: 6-K 6 month − 6-K 3 month · filed 2024-10-18 | -$10.78M 6-K · filed 2024-10-18 | -$15.49M derived: sum of 3 quarters · filed 2025-03-31 | -$19.09M derived: sum of 4 quarters · filed 2025-03-31 |
| 2023-03-31 | -$5.66M 6-K · filed 2023-05-16 | -$10.37M derived: sum of 2 quarters · filed 2025-03-31 | -$13.97M derived: sum of 3 quarters · filed 2025-03-31 | -$17.67M derived: sum of 4 quarters · filed 2025-03-31 |
| 2022-12-31 | -$4.71M derived: 20-F 12 month − 6-K 9 month · filed 2025-03-31 | -$8.31M derived: sum of 2 quarters · filed 2025-03-31 | -$12.01M derived: sum of 3 quarters · filed 2025-03-31 | -$14.77M 20-F · filed 2025-03-31 |
| 2022-09-30 | -$3.60M derived: 6-K 9 month − 6-K 6 month · filed 2023-11-16 | -$7.30M derived: sum of 2 quarters · filed 2023-11-16 | -$10.06M 6-K · filed 2023-11-16 | |
| 2022-06-30 | -$3.70M derived: 6-K 6 month − 6-K 3 month · filed 2023-08-15 | -$6.46M 6-K · filed 2023-08-15 | ||
| 2022-03-31 | -$2.76M 6-K · filed 2023-05-16 | |||
| 2021-12-31 | -$3.22M 20-F · filed 2024-04-09 | |||
| 2021-06-30 | -$132.53K 6-K · filed 2022-09-07 | |||
| 2020-12-31 | -$468.74K 20-F · filed 2023-04-07 | |||
| 2019-12-31 | -$416.50K 20-F · filed 2022-05-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |